ロード中...

Efficacy of mirabegron for overactive bladder with human T cell lymphotropic virus‐1 associated myelopathy

OBJECTIVE: Mirabegron is widely considered as an effective and safe drug for patients with overactive bladder (OAB). However, there is no evidence regarding the efficacy of mirabegron in human T cell lymphotropic virus‐1 (HTLV‐1)‐associated myelopathy/tropical spastic paraparesis (HAM/TSP) patients...

詳細記述

保存先:
書誌詳細
出版年:Low Urin Tract Symptoms
主要な著者: Matsuo, Tomohiro, Miyata, Yasuyoshi, Nakamura, Tatsufumi, Satoh, Katsuya, Sakai, Hideki
フォーマット: Artigo
言語:Inglês
出版事項: Blackwell Publishing Asia Pty Ltd 2018
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC7379193/
https://ncbi.nlm.nih.gov/pubmed/29473309
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/luts.12218
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!